Merdad Parsey - Nov 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol: GILD
Transactions as of: Nov 10, 2022
Transactions value $: -$187,337
Form type: 4
Date filed: 11/14/2022, 11:42 AM
Previous filing: Sep 12, 2022
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+5.1K	+11.93%		47.8K	Nov 10, 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$187K	-2.27K	-4.74%	$82.60	45.6K	Nov 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-5.1K	-10.15%		45.1K	Nov 10, 2022	Common Stock	5.1K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.